United Drug plc (UDG.L) reported that its six-month profit before tax decreased to 17.86 million euros from 28.12 million euros last year. Profit to owners of the parent was 13.13 million euros or 5.47 cent, compared to 23.03 million euros or 9.62 cent last year.
Adjusted profit before tax was 38 million euros, up 8% from last year. Adjusted profit per share increased to 12.58 cent from 11.80 cent last year.
Revenue for the six months was 1.02 billion euros, up 14% from last year. The Group said the increase was a result of organic growth and the impact of the acquisitions made towards the end of 2012. Each of the three divisions within the Group reported revenue ahead of the prior period.
The Board of United Drug plc has declared an interim dividend of 2.61 cent per share, a 5% increase on the 2012 interim dividend.
The Group continues to expect constant currency adjusted profit per share for the year to 30 September 2013, before non-recurring costs associated with acquisition activity and exceptional items, to be between 5% and 8% ahead of last year.
For comments and feedback: editorial@rttnews.com